SEARCH

SEARCH BY CITATION

References

  • 1
    Leonard JV, McKiernan PJ. The role of liver transplantation in urea cycle disorders. Mol Genet Metab 2004; 81: S74S78.
  • 2
    Whitington PF, Alonso EM, Boyle JT et al. Liver transplantation for the treatment of urea cycle disorders. J Inherit Metab Dis 1998; 21: 112118.
  • 3
    Burlina AB. Hepatocyte transplantation for inborn errors of metabolism. J Inherit Metab Dis 2004; 27: 373383.
  • 4
    Najimi M, Sokal E. Update on liver cell transplantation. J Pediatr Gastroenterol Nutr 2004; 39: 311319.
  • 5
    Fox IJ, Chowdhury JR, Kaufman SS et al. Treatment of the Crigler–Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998; 338: 14221426.
  • 6
    Muraca M, Gerunda G, Neri D et al. Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 2002; 359: 317318. Erratum in: Lancet 2002; 359: 1528.
  • 7
    Sokal EM, Smets F, Bourgois A et al. Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation 2003; 76: 735738.
  • 8
    Mitry RR, Dhawan A, Hughes RD et al. One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation 2004; 77: 16141616.
  • 9
    Horslen SP, McCowan TC, Goertzen TC et al. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 2003; 111: 12621267.
  • 10
    Darwish AA, Sokal E, Stephenne X, Najimi M, De Ville de Goyet J, Reding R. Permanent access to the portal system for cellular transplantation using an implantable port device. Liver Transpl 2004; 10: 12131215.
  • 11
    Li AP, Gorycki PD, Hengstler JG et al. Present status of the application of cryopreserved hepatocytes in the evaluation of xenobiotics: consensus of an international expert panel. Chem Biol Interact 1999; 121: 117123.
  • 12
    Gupta S, Jansen PLM, Klempnauer J, Manns MP. Hepatocyte transplantation, Vol. 126 Falk Symposium. Kluwer Academic Publishing, 2002.
  • 13
    Bumgardner GL, Li J, Heininger M, Ferguson RM, Orosz CG. In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model. Transplantation 1998; 65: 4752.
  • 14
    Dunn TB, Kumins NH, Raofi V et al. Multiple intrasplenic hepatocyte transplantations in the dalmatian dog. Surgery 2000; 127: 193199.
  • 15
    Jamal HZ, Weglarz TC, Sandgren EP. Cryopreserved mouse hepatocytes retain regenerative capacity in vivo. Gastroenterology 2000; 118: 390394.
  • 16
    Dandri M, Burda MR, Gocht A et al. Woodchuck hepatocytes remain permissive for hepadnavirus infection and mouse liver repopulation after cryopreservation. Hepatology 2001; 34: 824833.
  • 17
    Cho JJ, Joseph B, Sappal BS et al. Analysis of the functional integrity of cryopreserved human liver cells including xenografting in immunodeficient mice to address suitability for clinical applications. Liver Int 2004; 24: 361370.
  • 18
    Baccarani U, Donini A, Sanna A et al. First report of cryopreserved human hepatocytes based bioartificial liver successfully used as a bridge to liver transplantation. Am J Transplant 2004; 4: 286289.